newsfilter
← Latest News
PR Newswire·

Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research

Illumina, Inc. (NASDAQ: ILMN) today announced a new complete solution for molecular residual disease (MRD) research based on whole-genome sequencing...